All In Biotech

Drug Trial Radar · NCT03296527

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women

A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre, Pan-Asian Trial Comparing the Efficacy and Safety of FE 999049 With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing Assisted Reproductive Technology Programme

Last checked: Nov 19, 2026Latest source record: Aug 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,011 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,011

Actual

Start

Dec 1, 2017

Primary completion

Jan 3, 2020

Study completion Jul 26, 2020

Sponsor

Lead sponsor
Ferring PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Sep 28, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 20 years, up to 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To demonstrate non-inferiority of FE 999049 compared with GONAL-F with respect to ongoing pregnancy rate in women undergoing controlled ovarian stimulation.

Conditions

  • Controlled Ovarian Simulation

Interventions

  • Follitropin alfaDrug

    GONAL-F dose was fixed for the first 5 stimulation days.

  • Follitropin deltaDrug

    REKOVELLE (FE 999049) was fixed throughout the stimulation period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ongoing Pregnancy RateTime frame: 10-11 weeks after transfer

Locations

26 sites in 4 countries. Site status is shown where the registry gives one.

  • Beijing Obstetrics and Gynecology Hospital,Capital Medical University

    Beijing, China

  • Medical Center for Human Reproduction, Peking University Third Hospital

    Beijing, China

  • Peking University First Hospital

    Beijing, China

  • West China Second University Hospital of Sichuan University

    Chengdu, China

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou, China

  • The Sixth Affiliated Hospital of Sun Yat-sen University

    Guangzhou, China

  • The Third Affiliated Hospital of Guangzhou Medical University

    Guangzhou, China

  • The First Affiliated Hospital of An'hui Medical University

    Hefei, China

  • Jiangsu Province Hospital

    Nanjing, China

  • ShengJing Hospital of China Medical University

    Shenyang, China

  • Peking University Shenzhen Hospital

    Shenzhen, China

  • Tianjin Central Hospital of Gynaecology and Obstetrics

    Tianjin, China

  • Tianjin Medical University General Hospital

    Tianjin, China

  • Renmin Hospital of Wuhan University

    Wuhan, China

  • Tongji Hospital,Tongji Medical College, Huazhong University of Science & Technology

    Wuhan, China

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, China

  • Seoul National University Bundang Hospital

    Seongnam-si, South Korea

  • Asan Medical Center

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • Taichung Veterans General Hospital

    Taichung, Taiwan

  • National Taiwan University Hospital

    Taipei, Taiwan

  • Taipei Medical University Hospital

    Taipei, Taiwan

  • Chang Gung Memorial Hospital

    Taoyuan, Taiwan

  • National Center for Assisted Reproductive Technology

    Hanoi, Vietnam

  • My Duc Hospital

    Ho Chi Minh City, Vietnam

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.